Arizona State Retirement System Sells 7,973 Shares of Corteva, Inc. $CTVA

Arizona State Retirement System lowered its holdings in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 191,331 shares of the company’s stock after selling 7,973 shares during the quarter. Arizona State Retirement System’s holdings in Corteva were worth $12,825,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Activest Wealth Management lifted its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new position in Corteva during the third quarter valued at $25,000. True Wealth Design LLC lifted its position in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the last quarter. Redmont Wealth Advisors LLC bought a new position in Corteva during the third quarter valued at $29,000. Finally, Jackson Grant Investment Advisers Inc. lifted its position in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Insider Activity

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.15% of the company’s stock.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several research reports. The Goldman Sachs Group increased their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Citigroup increased their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Corteva in a research report on Wednesday. Berenberg Bank increased their price objective on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Finally, BNP Paribas Exane increased their price objective on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average price target of $85.19.

Get Our Latest Research Report on Corteva

Corteva Stock Up 0.2%

Shares of Corteva stock opened at $79.78 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market cap of $53.56 billion, a price-to-earnings ratio of 50.50, a PEG ratio of 2.73 and a beta of 0.68. The firm’s 50-day moving average is $80.09 and its two-hundred day moving average is $71.64. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63.

Corteva (NYSE:CTVAGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the business posted $0.32 EPS. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts expect that Corteva, Inc. will post 3.62 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.